deCODE reborn
A leaner version of the failed Icelandic genomics company, deCODE genetics, has emerged from the corporation's bankruptcy late last year. Dubbed the "New deCODE" in a company linkurl:statement;http://www.decode.com/news/news.php?story=112 released today (Jan 21), deCODE genetics ehf will focus less on in-house drug discovery, instead partnering with drug makers to translate its genetic discoveries into therapies. The new company will also continue to sell its diagnostics disease risk tests and i
Written byBob Grant
From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer.
View Full Profile
Learn about our Editorial Policies.
| 1 min read
Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share
**__Related stories:__***linkurl:deCODE files for bankruptcy;http://www.the-scientist.com/blog/display/56152/
[17th November 2009]*linkurl:deCODE close to broke;http://www.the-scientist.com/blog/display/55884/
[11th August 2009]*linkurl:deCODE falls from NASDAQ grace;http://www.the-scientist.com/blog/display/55200/
[18th November 2008]
Interested in reading more?
The Scientist ARCHIVES
Become a Member of
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
Meet the Author
From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer. Before joining the team, he worked as a reporter at Audubon and earned a master’s degree in science journalism from New York University. In his previous life, he pursued a career in science, getting a bachelor’s degree in wildlife biology from Montana State University and a master’s degree in marine biology from the College of Charleston in South Carolina. Bob edited Reading Frames and other sections of the magazine.
View Full Profile
Share
